aditx
therapeutics
announces
closing
upsized
million
public
offering
loma
linda
ca
globe
newswire
via
newmediawire
aditx
therapeutics
aditxt
company
nasdaq
adtx
life
sciences
company
developing
biotechnologies
specifically
focused
improving
health
immune
system
immune
monitoring
reprogramming
today
announced
closing
previously
announced
upsized
million
underwritten
public
offering
units
unit
consisting
one
share
common
stock
one
series
warrant
one
series
warrant
series
warrants
permit
holder
purchase
one
share
common
stock
exercise
price
per
share
expire
years
series
warrants
exercisable
per
share
expire
years
series
warrants
contain
exchange
feature
permit
holder
exchange
warrant
shares
common
stock
basis
time
commencing
earlier
trading
days
offering
million
volume
traded
company
common
stock
closing
stock
price
company
common
stock
date
exercise
exercise
price
series
warrant
underwriters
continue
hold
option
purchase
additional
shares
common
stock
unit
sold
price
common
stock
accompanying
warrants
included
units
purchased
together
offering
issued
separately
immediately
separable
upon
issuance
company
also
offering
purchasers
whose
purchase
common
stock
offering
would
otherwise
result
purchaser
together
affiliates
certain
related
parties
beneficially
owning
company
outstanding
common
stock
immediately
following
consummation
offering
opportunity
lieu
purchasing
common
stock
purchase
series
convertible
preferred
stock
preferred
stock
share
preferred
stock
sold
together
warrants
described
sold
share
common
stock
share
preferred
stock
purchased
offering
lieu
common
stock
company
reduce
number
shares
common
stock
sold
offering
basis
company
intend
apply
listing
either
warrants
preferred
stock
nasdaq
capital
market
securities
exchange
nationally
recognized
trading
system
expect
market
develop
preferred
stock
series
warrants
series
warrants
dawson
james
securities
acted
sole
manager
offering
sheppard
mullin
richter
hampton
llp
acted
counsel
company
connection
offering
registration
statement
relating
offering
securities
declared
effective
securities
exchange
commission
sec
september
copies
registration
statement
accessed
visiting
sec
website
offering
made
means
prospectus
copy
final
prospectus
relating
offering
may
obtained
visiting
sec
website
dawson
james
securities
federal
highway
floor
boca
raton
florida
attention
prospectus
department
telephone
email
syndicate
press
release
constitute
offer
sell
solicitation
offer
buy
securities
described
herein
shall
sale
securities
state
jurisdiction
offer
solicitation
sale
would
unlawful
prior
registration
qualification
securities
laws
state
jurisdiction
aditx
therapeutics
aditxt
developing
technologies
specifically
focused
improving
health
immune
system
immune
monitoring
reprogramming
immune
monitoring
technology
designed
provide
personalized
comprehensive
profile
immune
system
immune
reprogramming
technology
currently
stage
designed
retrain
immune
system
induce
tolerance
objective
addressing
rejection
transplanted
organs
autoimmune
diseases
allergies
information
please
visit
statements
certain
statements
press
release
constitute
statements
within
meaning
federal
securities
laws
statements
include
statements
regarding
company
intentions
beliefs
projections
outlook
analyses
current
expectations
concerning
among
things
company
ongoing
planned
product
development
company
intellectual
property
position
company
ability
develop
commercial
functions
expectations
regarding
product
launch
revenue
company
results
operations
cash
needs
spending
financial
condition
liquidity
prospects
growth
strategies
industry
company
operates
trends
may
affect
industry
company
statements
based
upon
current
estimates
assumptions
subject
various
risks
uncertainties
including
without
limitation
set
forth
company
filings
securities
exchange
commission
risk
factors
relating
business
contained
therein
available
sec
website
thus
actual
results
could
materially
different
company
expressly
disclaims
obligation
update
alter
statements
whether
result
new
information
future
events
otherwise
except
required
law
investor
relations
pcg
advisory
jeff
ramson
chief
executive
officer
ir
